Abeona Therapeutics Current Ratio 2010-2022 | ABEO
Abeona Therapeutics current ratio from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Abeona Therapeutics Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2022-09-30 |
$0.03B |
$0.01B |
2.02 |
2022-06-30 |
$0.03B |
$0.01B |
2.21 |
2022-03-31 |
$0.04B |
$0.01B |
3.18 |
2021-12-31 |
$0.06B |
$0.02B |
3.39 |
2021-09-30 |
$0.07B |
$0.03B |
2.57 |
2021-06-30 |
$0.08B |
$0.04B |
1.88 |
2021-03-31 |
$0.09B |
$0.04B |
2.17 |
2020-12-31 |
$0.10B |
$0.04B |
2.33 |
2020-09-30 |
$0.11B |
$0.04B |
2.70 |
2020-06-30 |
$0.11B |
$0.04B |
2.90 |
2020-03-31 |
$0.12B |
$0.04B |
3.24 |
2019-12-31 |
$0.13B |
$0.04B |
3.42 |
2019-09-30 |
$0.05B |
$0.02B |
2.45 |
2019-06-30 |
$0.07B |
$0.03B |
2.54 |
2019-03-31 |
$0.07B |
$0.02B |
3.35 |
2018-12-31 |
$0.09B |
$0.02B |
4.37 |
2018-09-30 |
$0.12B |
$0.01B |
11.09 |
2018-06-30 |
$0.12B |
$0.01B |
21.07 |
2018-03-31 |
$0.13B |
$0.01B |
20.79 |
2017-12-31 |
$0.14B |
$0.01B |
25.07 |
2017-09-30 |
$0.06B |
$0.00B |
22.13 |
2017-06-30 |
$0.06B |
$0.00B |
14.05 |
2017-03-31 |
$0.06B |
$0.01B |
10.52 |
2016-12-31 |
$0.07B |
$0.01B |
8.37 |
2016-09-30 |
$0.03B |
$0.01B |
4.90 |
2016-06-30 |
$0.04B |
$0.01B |
3.98 |
2016-03-31 |
$0.04B |
$0.01B |
4.95 |
2015-12-31 |
$0.04B |
$0.00B |
27.47 |
2015-09-30 |
$0.04B |
$0.00B |
27.83 |
2015-06-30 |
$0.03B |
$0.00B |
16.13 |
2015-03-31 |
$0.01B |
$0.00B |
6.61 |
2014-12-31 |
$0.01B |
$0.00B |
3.99 |
2014-09-30 |
$0.00B |
$0.01B |
0.02 |
2014-06-30 |
$0.00B |
$0.01B |
0.02 |
2014-03-31 |
$0.00B |
$0.01B |
0.04 |
2013-12-31 |
$0.00B |
$0.01B |
0.06 |
2013-09-30 |
$0.00B |
$0.01B |
0.13 |
2013-06-30 |
$0.00B |
$0.01B |
0.30 |
2013-03-31 |
$0.00B |
$0.01B |
0.22 |
2012-12-31 |
$0.00B |
$0.01B |
0.25 |
2012-09-30 |
$0.00B |
$0.01B |
0.10 |
2012-06-30 |
$0.00B |
$0.01B |
0.15 |
2012-03-31 |
$0.00B |
$0.01B |
0.22 |
2011-12-31 |
$0.00B |
$0.01B |
0.27 |
2011-09-30 |
$0.00B |
$0.01B |
0.12 |
2011-06-30 |
$0.00B |
$0.01B |
0.35 |
2011-03-31 |
$0.01B |
$0.02B |
0.42 |
2010-12-31 |
$0.01B |
$0.01B |
0.57 |
2010-09-30 |
$0.00B |
$0.01B |
0.11 |
2010-06-30 |
$0.00B |
$0.01B |
0.35 |
2010-03-31 |
$0.00B |
$0.01B |
0.51 |
2009-12-31 |
$0.00B |
$0.01B |
0.08 |
2009-09-30 |
$0.00B |
$0.01B |
0.22 |
2009-06-30 |
$0.00B |
$0.01B |
0.18 |
2009-03-31 |
$0.00B |
$0.01B |
0.38 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.047B |
$0.003B |
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
|